Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment Strategies Used in Treating Myelofibrosis: State of the Art.
Martino M, Pitea M, Sgarlata A, Delfino IM, Cogliandro F, Scopelliti A, Marafioti V, Polimeni S, Porto G, Policastro G, Utano G, Pellicano M, Leanza G, Alati C. Martino M, et al. Among authors: marafioti v. Hematol Rep. 2024 Oct 30;16(4):698-713. doi: 10.3390/hematolrep16040067. Hematol Rep. 2024. PMID: 39584924 Free PMC article. Review.
First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study.
Martino M, Gori M, Porto G, Policastro G, Pitea M, Sgarlata A, Delfino IM, Cogliandro F, Scopelliti A, Utano G, Pellicano M, Idato A, Vincelli ID, Marafioti V, Micò MC, Lazzaro G, Loteta B, Alati C, Leanza G, D'Arrigo G, Tripepi GL, Pitino A. Martino M, et al. Among authors: marafioti v. Cancers (Basel). 2024 Sep 27;16(19):3307. doi: 10.3390/cancers16193307. Cancers (Basel). 2024. PMID: 39409927 Free PMC article.
Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024?
Alati C, Pitea M, Mico MC, Marafioti V, Greve B, Pratico G, Loteta B, Cogliandro F, Porto G, Policastro G, Utano G, Sgarlata A, Imbalzano L, Delfino IM, Montechiarello E, Germano J, Filippelli G, Martino M. Alati C, et al. Among authors: marafioti v. Expert Rev Hematol. 2024 Aug;17(8):515-525. doi: 10.1080/17474086.2024.2382300. Epub 2024 Jul 21. Expert Rev Hematol. 2024. PMID: 39017205 Review.
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience.
Iula R, De Novellis D, Trastulli F, Della Pepa R, Fontana R, Carobene A, Di Perna M, D'Ambrosio A, Romano M, Leone A, De Fazio L, Fiumarella A, Gaeta G, Marafioti V, Barbato S, Palmieri S, Rocco S, Serio B, Califano C, Pane F, Ferrara F, Giudice V, Selleri C, Catalano L. Iula R, et al. Among authors: marafioti v. Front Oncol. 2022 Nov 15;12:1026251. doi: 10.3389/fonc.2022.1026251. eCollection 2022. Front Oncol. 2022. PMID: 36457484 Free PMC article.
34 results